Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 309, doi. 10.1093/ijnp/pyad012
- By:
- Publication type:
- Article
Works matching IS 14611457 AND DT 2023 AND VI 26 AND IP 5
Results: 6
1
2
New Developments in the Treatment of Schizophrenia: An Expert Roundtable.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 322, doi. 10.1093/ijnp/pyad011
- By:
- Publication type:
- Article
3
A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 331, doi. 10.1093/ijnp/pyad014
- By:
- Publication type:
- Article
4
IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 359, doi. 10.1093/ijnp/pyad013
- By:
- Publication type:
- Article
5
Sex and Estrous Cycle Are Not Mediators of S-Ketamine's Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 350, doi. 10.1093/ijnp/pyad016
- By:
- Publication type:
- Article
6
Distinct Situational Cue Processing in Individuals with Kleptomania: A Preliminary Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2023, v. 26, n. 5, p. 340, doi. 10.1093/ijnp/pyad005
- By:
- Publication type:
- Article